To evaluate the safety and efficacy of single IV doses of N1539 after dental impaction surgery.
This is a randomized, double-blind, placebo-controlled, single center study in subjects who have undergone third molar extraction surgery. Eligible subjects will have surgical removal of \>2 third molars, of which at least 1 must be a complete or partial mandibular impaction. Each subject's study participation will consist of a screening visit (1-21 days prior to surgery), an inpatient evaluation period of 24 hours following dosing, and a follow-up phone call 3-5 days postdose.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
230
Jean Brown Research
Salt Lake City, Utah, United States
Pain Intensity Difference at End of Study
Time frame: 0-24 hours
Onset of action
Time frame: 0-1 hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
60 mg
400 mg